These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3080207)

  • 1. National Institutes of Health Consensus Development Conference Statement: Adjuvant Chemotherapy for Breast Cancer. September 9-11, 1985.
    CA Cancer J Clin; 1986; 36(1):42-7. PubMed ID: 3080207
    [No Abstract]   [Full Text] [Related]  

  • 2. The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer--a commentary.
    Lippman ME
    Breast Cancer Res Treat; 1985; 6(3):195-200. PubMed ID: 3841498
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus conference. Adjuvant chemotherapy for breast cancer.
    JAMA; 1985 Dec; 254(24):3461-3. PubMed ID: 4068189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on September 1985 NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer.
    Greenspan EM
    Cancer Invest; 1986; 4(5):471-5. PubMed ID: 3542143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant therapy for node-negative breast cancer: a proactive view.
    Glick JH
    Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen and combination chemotherapy as adjuvant treatment in postmenopausal women with breast cancer.
    Wallgren A; Baral E; Beling U; Carstensen J; Friberg S; Glas U; Kaigas M; Skoog L
    Recent Results Cancer Res; 1984; 96():197-203. PubMed ID: 6396775
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status.
    Rivkin SE; Knight WA; McDivitt R; Cruz T; Foulkes M; Osborne CK; Fabian CJ; Costanzi JJ
    World J Surg; 1985 Oct; 9(5):723-7. PubMed ID: 3840629
    [No Abstract]   [Full Text] [Related]  

  • 10. The present status of the adjuvant endocrine treatment.
    Jonat W; Maass H
    J Steroid Biochem; 1987; 27(1-3):499-502. PubMed ID: 3320540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant systemic therapy of breast cancer.
    Lippman ME
    Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemo- or endocrine adjuvant therapy alone or combined in postmenopausal patients (GABG Trial 1).
    Jonat W; Kaufmann M; Abel U
    Recent Results Cancer Res; 1989; 115():163-9. PubMed ID: 2696028
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 14. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.
    Lippman ME; Chabner BA
    NCI Monogr; 1986; (1):5-10. PubMed ID: 3534591
    [No Abstract]   [Full Text] [Related]  

  • 15. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group.
    Boccardo F; Rubagotti A; Bruzzi P; Cappellini M; Isola G; Nenci I; Piffanelli A; Scanni A; Sismondi P; Santi L
    J Clin Oncol; 1990 Aug; 8(8):1310-20. PubMed ID: 2199618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year results.
    Jakesz R; Reiner G; Schemper M; Reiner A; Blijham G; Rainer H; Dittrich D; Spona J; Schutte B; Reynders M
    Recent Results Cancer Res; 1989; 115():180-5. PubMed ID: 2696031
    [No Abstract]   [Full Text] [Related]  

  • 18. Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
    Gelber RD
    Recent Results Cancer Res; 1984; 96():102-9. PubMed ID: 6396763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in breast cancer. Report and commentary on the NIH Consensus Development Conference, Bethesda, Maryland, U.S. 9-11 September, 1985].
    Jakesz R
    Wien Klin Wochenschr; 1985 Nov; 97(21):825-7. PubMed ID: 2865856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.